Fable Therapeutics
Amanda Baumholtz, Ph.D., is a highly accomplished scientist with extensive experience in antibody and peptide discovery, molecular biology, and clinical research. Currently serving as Principal Scientist at Fable Therapeutics, Amanda previously held senior positions at Xilio Therapeutics, Inc. and KisoJi Biotechnology Inc., where notable achievements included developing in-house antibody and peptide library generation capabilities and designing various antibody constructs. Amanda's academic background includes a Ph.D. in Human/Medical Genetics and postdoctoral research in Experimental Medicine, both from McGill University, complemented by a Graduate Certificate in Business Administration from Concordia University. Amanda has a strong publication record and has received multiple awards for presentations at scientific conferences, demonstrating a commitment to advancing biomedical research and training future scientists.
This person is not in any teams
Fable Therapeutics
Fable Therapeutics Inc. was founded with a conviction to revolutionize drug discovery through the purposeful integration of AI techniques. Our cross-functional team of ML scientists and drug hunters collaborate to design novel medicines with expanded therapeutic potential. With this passion and vision, we’re designing the future of drug discovery.